Clinical trial
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With…
NCT01128894 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT01128894 |
|---|---|
| Title | A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. |
| Official title | A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Biological, Drug |
| Interventions | albiglutide, liraglutide |
| Enrollment | 841 |
| Start date | May 1, 2010 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | May 24, 2010 |
| Last update posted | Feb 23, 2017 |
| Countries | Australia, Israel, Peru, Philippines, South Korea, Spain, United Kingdom, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: